Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions.
8/1/2010 J Transl Med. 2010 Aug 3;8:75 Yang WZ, Zhang Y, Wu F, Min WP, Minev B, Zhang M, Luo XL, Ramos F, Ichim TE, Riordan NH, Hu X. Background: The current paradigm for cord blood transplantation is that HLA matching and immune suppression are strictly required to prevent graft versus host disease (GVHD). Immunological…